{
  "id": 6840058,
  "title": "IXJ vs XPH: Global Healthcare ETF or Pharma Focus?",
  "url": "https://urgent.news/2026/09/12/ixj-vs-xph-global-healthcare-etf-or-pharma-focus-6840058",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-12T01:49:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/ixj-vs-xph-global-healthcare-etf-or-pharma-focus"
  },
  "original_language": "en",
  "account": null,
  "summary": "The iShares Global Healthcare ETF and the State Street SPDR S&P Pharmaceuticals ETF offer different approaches to investing in the healthcare sector. The iShares ETF provides broad sector coverage, according to Nasdaq Markets.\n\nThe iShares Global Healthcare ETF offers broad sector diversification and lower volatility, while the State Street SPDR S&P Pharmaceuticals ETF provides concentrated exposure to US drugmakers, as per Motley Fool.\n\nThese two funds differ in geographical reach, concentration, and historical risk profiles. The iShares ETF has a higher dividend yield than the State Street SPDR S&P Pharmaceuticals ETF, Nasdaq Markets reports.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "IXJ vs XPH: Global Healthcare ETF or Pharma Focus?",
        "url": "https://urgent.news/2026/09/12/ixj-vs-xph-global-healthcare-etf-or-pharma-focus",
        "published": "2026-09-12T01:29:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}